<DOC>
	<DOC>NCT00520169</DOC>
	<brief_summary>This is an open label, single-center study to determine the absolute bioavailability and nasopharyngeal absorption of PMI-150 (intranasal ketamine) 30 mg in healthy adult volunteers.</brief_summary>
	<brief_title>Absolute Bioavailability and Nasopharyngeal Absorption of Intranasal Ketamine</brief_title>
	<detailed_description>To examine the safety and assess the absolute bioavailability and nasopharyngeal absorption of PMI-150 30mg.</detailed_description>
	<mesh_term>Ketamine</mesh_term>
	<criteria>Healthy adults under 18 years</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>bioavailability</keyword>
</DOC>